The Microbicide Trials Network brings together international investigators and community and industry partners whose work is focused on the rigorous evaluation of promising microbicides.
“A Look Back …” is an occasional series to honor the communities, researchers, staff and study participants who have made countless and meaningful contributions to the work of the MTN since 2006.
To keep updated on the impact of the COVID-19 pandemic on our studies, visit our COVID-19 Response page.
Studies at the Microbicide Trials Network are designed specifically to support the potential licensure and regulatory approval of HIV prevention products for populations most vulnerable to HIV.
The MTN partners with key civil society groups and other stakeholders to solicit their views on proposed studies and to discuss issues related to study implementation.
The DELIVER and B-PROTECTED Studies: 3 things you need to know.
MTN is excited to share that the DELIVER study has completed enrollment of the first group of 150 participants.
Results of a sub-study of DELIVER called MTN-042B was published on March 31 in PLOS ONE.
Babies on Board! Meet the next generation of our MTN family.
View the MTN Babies Album here.
Read "Finding the Silver Lining" - in MTN's "A Look Back..." series.
Study finds adolescent girls and young women in Africa will use HIV prevention products
10,000-plus medical charts provides comparator for HIV prevention study in pregnant women
90-day dapivirine ring for women's HIV prevention passes its first test in Phase I study
Microbicide Trials Network